Safety of third SARS-CoV-2 vaccine (booster dose) during pregnancy.

ABSTRACT:

Background

COVID-19 during pregnancy is associated with adverse outcomes for both the mother and fetus. SARS-CoV-2 vaccination has significantly reduced the risk for symptomatic disease. Several studies have reported on the safety of SARS-CoV-2 vaccination during pregnancy, with no adverse effects on the obstetrical outcomes. However, data regarding the obstetrical outcomes following a booster dose of the SARS CoV-2 vaccination during pregnancy have not yet to be published.

Objective

This study aimed to examine the association between the booster dose of the SARS CoV-2 vaccination during pregnancy and obstetrical outcomes.

Study design

This was a retrospective cohort study of women who delivered between July and October 2021 at a large tertiary medical center. We comp

SUBMITTER: Dick A 

PROVIDER: S-EPMC8988438 | biostudies-literature | 2022 Jul

REPOSITORIES: biostudies-literature